Recent Blog Articles
Nicotine addiction explained — and how medications can help
Is your vision impaired? Tips to cope
Misgendering: What it is and why it matters
Healthy brain, healthier heart?
Stories connect us
Wondering about a headline-grabbing drug? Read on
Respiratory virus cases tick upward: What parents should know
Hope: Why it matters
Will new guidelines for heart failure affect you?
Want probiotics but dislike yogurt? Try these foods
The prostate is a golf-ball-sized gland that sits between the bladder and the penis. It secretes fluid that nourishes and protects sperm. Most older men have some cancer cells in their prostate glands. But because these cells usually grow slowly, they don't cause symptoms or affect health in most men. That said, about 230,000 American men are diagnosed with prostate cancer each year, and nearly 30,000 die of it.
Exactly why some men develop full-blown prostate cancer and others don't is a mystery. But researchers have identified several factors that raise a man's risk of the disease. These include:
Age. Older men are far more likely to develop prostate cancer than younger men.
Race. African-American men are more likely to get prostate cancer than other men, and to be diagnosed with more advanced-stage cancer.
Family history. A man whose father or brother has been diagnosed with prostate cancer is two to three times more likely to develop prostate cancer than a man who doesn't have family members with the disease.
Lifestyle. Men who eat a lot of red meat or high-fat dairy products seem to have a higher risk of prostate cancer.
Treatments for prostate cancer include an operation to remove the prostate (prostatectomy) and radiation therapy. Both often cause side effects such as incontinence and erectile dysfunction. Since early treatment with surgery or radiation doesn't necessarily "cure" the disease, and prevents relatively few men from dying from prostate cancer, more and more men are opting for a strategy known as watchful waiting or active surveillance. They and their doctors monitor the low-risk cancer closely and choose treatment only when the disease appears to make threatening moves toward growing and spreading.
A new treatment for advanced prostate cancer improves survival in phase 3 clinical trial
MRI looking better for detecting prostate cancer
American Heart Association issues statement on cardiovascular side effects from hormonal therapy for prostate cancer
New ways to test for prostate cancer
Predicting low-risk prostate cancer